Sun Pharmaceutical to acquire shares of Israeli firm Tarsius Pharma for USD 3 million

Tarsius Pharma is an early stage research and development company focusing on development of drug candidates in the field of ophthalmology.

Published: 10th September 2018 05:44 PM  |   Last Updated: 10th September 2018 05:44 PM   |  A+A-

Sun Pharmaceutical

Sun Pharmaceutical Industries ( Photo| REUTERS)


NEW DELHI: Drug major Sun Pharmaceutical Industries Monday said it has agreed to acquire 18.75 per cent shares of Israel-based Tarsius Pharma for a cash consideration of USD 3 million (over Rs 21 crore).

One of the company's wholly-owned subsidiaries has agreed to acquire 3,45,622 ordinary shares of Tarsius Pharma, of nominal value of NIS 0.01 each by way of subscription, representing 18.75 per cent of shares of Tarsius on a fully diluted basis, Sun Pharma said in a filing to BSE.

ALSO READ | Sun Pharma gets USFDA nod for prostate cancer drug

"Cost of acquisition is USD 3 million," it added.

The indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said.

Tarsius is an early stage research and development company focusing on development of drug candidates in the field of ophthalmology, it added.

Shares of Sun Pharmaceutical Industries closed at Rs 639.50 per scrip on BSE, down 3.72 per cent from its previous close.

Stay up to date on all the latest Business news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp